SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-16-000117
Filing Date
2016-05-09
Accepted
2016-05-09 16:34:10
Documents
61
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q halo1q2016-10q.htm 10-Q 859661
2 EXHIBIT 31.1 ex311q12016.htm EX-31.1 17197
3 EXHIBIT 31.2 ex312q12016.htm EX-31.2 17245
4 EXHIBIT 32 ex32q12016.htm EX-32 19992
11 slide1a04.jpg GRAPHIC 105055
12 slide2a04.jpg GRAPHIC 179858
  Complete submission text file 0001159036-16-000117.txt   4900795

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT halo-20160331.xml EX-101.INS 838010
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20160331.xsd EX-101.SCH 38638
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20160331_cal.xml EX-101.CAL 61163
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20160331_def.xml EX-101.DEF 150571
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20160331_lab.xml EX-101.LAB 504724
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20160331_pre.xml EX-101.PRE 265439
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 161632150
SIC: 2836 Biological Products, (No Diagnostic Substances)